GlassScriptPhysician profile
Lori Armstrong
NPI 1548708282
$1,617.75
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $887 · 2022: $95.84 · 2023: $531 · 2024: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $255.16 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $159.47 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $156.26 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.93 | 2021-2023 | Tradjenta, Jardiance |
| Amgen INC. | $134.82 | 2021-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $108.49 | 2021-2023 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $94.98 | 2021-2023 | |
| Gilead Sciences, INC. | $86.92 | 2023 | |
| Scynexis, INC. | $70.60 | 2022 | |
| Boston Scientific Corporation | $68.84 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $59.23 | 2021-2023 | Pifeltro, Delstrigo |
| Pfizer INC. | $56.89 | 2021-2023 | |
| Esperion Therapeutics, INC. | $46.86 | 2021 | |
| Paratek Pharmaceuticals, INC. | $39.80 | 2023 | Nuzyra |
| Exact Sciences Corporation | $33.14 | 2023 | Cologuard Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $33.12 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $27.49 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.71 | 2021 | |
| Allergan, INC. | $13.03 | 2021 | |
| Horizon Therapeutics Plc | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.